Details for: TRINTELLIX
Company: LUNDBECK CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02432919 | TRINTELLIX | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) | 5 MG | TABLET | ORAL |
| 02432927 | TRINTELLIX | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) | 10 MG | TABLET | ORAL |
| 02432943 | TRINTELLIX | VORTIOXETINE (VORTIOXETINE HYDROBROMIDE) | 20 MG | TABLET | ORAL |
Summary Reports
Summary Basis of Decision
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-norepinephrine Reuptake Inhibitors (SNRIs) - Assessing the Potential Risk of Sexual Dysfunction despite Treatment Discontinuation
Summary Safety Review - Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin-norepinephrine Reuptake Inhibitors (SNRIs) - Assessing the Potential Risk of Sexual Dysfunction despite Treatment Discontinuation
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.